Skip to content
Riskpilot
← Back to search
Sign in
Get full access
TRACER PHARMA ApS
APS
In liquidation
Advertising protection
CVR 34090106
Agern Alle 7, 2970
Hørsholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2011 · 14 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
TRACER PHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
1M
3M
4M
6M
4M
2021
4M
2022
4M
2023
5M
2024
5M
2025
EBITDA
DKK millions
3M
2M
1M
1M
0M
1M
2021
0M
-100%
2022
0M
0%
2023
2M
+200%
2024
1M
-50%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
3.968
3.883
4.076
5.413
5.204
Staff expenses
-2.760
-3.552
-3.807
-2.906
-4.607
EBITDA
1.208
331
269
2.250
854
Depreciation & amort.
-119
-122
-122
-67
-40
EBIT
1.089
209
147
2.183
813
Net financials
-22
-23
-22
4
94
Profit before tax
1.067
186
126
2.186
907
Tax
235
41
29
481
220
Net profit
832
145
97
1.705
688
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
3.250
3.439
3.025
4.662
2.272
Equity
1.482
1.627
1.374
2.079
867
Long-term debt
0
0
0
461
0
Short-term debt
1.734
1.809
1.651
1.865
1.404
Total debt
1.734
1.809
1.651
2.326
1.404
Financial ratios
5-year trend
EBITDA margin (of gross profit)
16.4%
This company
2021
2025
Equity ratio
38.2%
This company
38.2%
Market median
+0% vs market
2021
2025
Return on equity
79.3%
This company
18.4%
Market median
+331% vs market
2021
2025
Net profit margin (of gross profit)
13.2%
This company
2021
2025
Asset turnover (of gross profit)
2.29×
This company
2021
2025
Debt / equity
1.62×
This company
0.62×
Market median
-161% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
View
PDF
More on TRACER PHARMA ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
